ORCA
Online Research @ Cardiff

Clear Cookie - decide language by browser settings

Browse by Current Cardiff authors

Number of items: 12.

Jones, Ashley T., Narov, Kalin, Yang, Jian, Sampson, Julian R. and Shen, Ming Hong 2019. Efficacy of dual inhibition of glycolysis and glutaminolysis for therapy of renal lesions in Tsc2+/− Mice1. NEOPLASIA 21 (2) , pp. 230-238. 10.1016/j.neo.2018.12.003

Johnson, Charlotte E., Dunlop, Elaine A., Seifan, Sara, McCann, Henry D., Hay, Trevor, Parfitt, Geraint J., Jones, Ashley T., Giles, Peter J., Shen, Ming H., Sampson, Julian R., Errington, Rachel J., Davies, David Mark and Tee, Andrew R. 2018. Loss of tuberous sclerosis complex 2 sensitizes tumors to nelfinavir−bortezomib therapy to intensify endoplasmic reticulum stress-induced cell death. Oncogene 37 , pp. 5913-5925. 10.1038/s41388-018-0381-2

Shen, Ming, Samsel, Paulina, Shen, Louise L., Narov, Kalin, Yang, Jian and Sampson, Julian 2017. Assessment of response of kidney tumours to rapamycin and atorvastatin in Tsc1+/- mice. Translational Oncology 10 (5) , pp. 793-799. 10.1016/j.tranon.2017.07.009

Narov, Kalin, Yang, Jian, Samsel, Paulina, Jones, Ashley, Sampson, Julian R and Shen, Ming Hong 2017. The dual PI3K/mTOR inhibitor GSK2126458 is effective for treating solid renal tumours in Tsc2+/- mice through suppression of cell proliferation and induction of apoptosis. Oncotarget , 17215. 10.18632/oncotarget.17215

Yang, Jian, Samsel, Paulina A., Narov, Kalin, Jones, Ashley, Gallacher, Daniel, Gallacher, John, Sampson, Julian Roy and Shen, Ming Hong 2017. Combination of everolimus with sorafenib for solid renal tumours in Tsc2+/- mice is superior to everolimus alone. Neoplasia 19 (2) , pp. 112-120. 10.1016/j.neo.2016.12.008

Dodd, Kayleigh, Yang, Jian, Shen, Ming, Sampson, Julian Roy and Tee, Andrew 2015. mTORC1 drives HIF-1α and VEGF-A signalling via multiple mechanisms involving 4E-BP1, S6K1 and STAT3. Oncogene 34 (17) , pp. 2239-2250. 10.1038/onc.2014.164

Yang, Jian, Kalogerou, M, Samsel, Paulina, Zhang, Y., Griffiths, David, Gallacher, John, Sampson, Julian and Shen, Ming 2015. Renal tumours in a Tsc2+/- mouse model do not show feedback inhibition of Akt and are effectively prevented by rapamycin. Oncogene 34 , pp. 922-931. 10.1038/onc.2014.17

Yang, Jian, Kalogerou, M., Gallacher, John, Sampson, Julian and Shen, Ming 2013. Renal tumours in a Tsc1+/- mouse model show epigenetic suppression of organic cation transporters Slc22a1, Slc22a2 and Slc22a3, and do not respond to metformin. European Journal of Cancer 49 (6) , pp. 1479-1490. 10.1016/j.ejca.2012.10.027

Kalogerou, Maria, Zhang, Yadan, Yang, Jian, Garrahan, Nigel John, Paisey, Stephen James, Tokarczuk, Pawel, Stewart, Andrew, Gallacher, John Edward, Sampson, Julian Roy and Shen, Ming Hong 2012. T2 weighted MRI for assessing renal lesions in transgenic mouse models of tuberous sclerosis. European Journal of Radiology 81 (9) , pp. 2069-2074. 10.1016/j.ejrad.2011.06.054

Shen, Ming Hong, Mantripragada, Kiran Kumar, Dumanski, J. P., Frayling, Ian Martin and Upadhyaya, Meena 2007. Detection of copy number changes at the NF1 locus with improved high-resolution array CGH. Clinical Genetics 72 (3) , pp. 238-244. 10.1111/j.1399-0004.2007.00858.x

Shen, Ming Hong, Mantripragada, Kiran Kumar, Dumanski, J., Frayling, Ian and Upadhyaya, Meena 2006. DNA microarray for detection of copy number changes at the NF1 locus using array comparative genomic hybridisation (CGH) analysis [Abstract]. Journal of Medical Genetics 43 (Supp.) , S19.

Shen, Ming Hong 1999. Neurofibromatosis type 1. In: Kurzrock, R. and Talpaz, M. eds. Molecular biology in cancer medicine, 2nd ed., London: Martin Dunitz, pp. 493-514.

This list was generated on Mon Mar 18 03:57:22 2019 GMT.

Export as	Atom RSS 1.0 RSS 2.0